Prevalence and Type Distribution of Human Papillomavirus Infection Using the INNo-Lipa Assay, Kerman, Southeast Iran

被引:12
|
作者
Afshar, Reza Malekpour [1 ]
Mollaie, Hamid Reza [3 ]
Fazlalipour, Mehdi [3 ]
Arabzadeh, Seyad Alimohammad [2 ]
机构
[1] Kerman Univ Med Sci, Res Ctr Trop & Infect Dis, Kerman, Iran
[2] Kerman Univ Med Sci, Dept Med Virol, Kerman, Iran
[3] Iran Univ Med Sci, Dept Med Virol, Tehran, Iran
关键词
Human papilloma virus; subtypes; INNo-lipa assay; Kerman; Iran; CERVICAL INTRAEPITHELIAL NEOPLASIA; GENOTYPING EXTRA ASSAY; HPV INFECTION; PAP-SMEAR; WOMEN; CANCER; SPECIMENS; CYTOLOGY; LESIONS; DNA;
D O I
10.7314/APJCP.2013.14.9.5287
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The human papilloma virus (HPV) causes skin and mucous membrane infections. It crosses from one person to another by skin-to-skin contact, such as sexual contact. There are more than 100 types of HPV that can influence different parts of the body. Some types of HPV can cause cancer (such as cervical or anal cancer) and others can cause warts (such as genital or plantar warts). HPV infection is one of the most common sexually transmitted infections (STIs) in Iran and around the world. Considerable molecular evidence suggests a role for human papilloma virus (HPV) in the pathogenesis of carcinoma. Epidemiological studies on human papilloma viruses (HPVs) infections in general population are critical for the performing of health policy guidelines for developing the strategies to hinder the primary and secondary different cancer. In different parts of Iran, there is a lack of population-based studies to determine the prevalence of HPV in the general population. The aim of this population-based study was therefore to report the prevalence ratse of HPV types among Iranian patients. To study the risk of human papilloma virus (HPV) infection, we managed a retrospective study in Kerman province, southeast of Iran. For this purpose, 410 patients tested for the presence of HPV DNA using PCR and INNo-Lipa assays. HPV DNA was detected in 108 out of 410 patients (26.34%), while it was not detected in any of the control group samples. Patients included 23 (21.1%) males and 86 (78.8%) females. HPV type 6 was the most common (49%) followed by HPV type 16 (10.1%), and also HPV type11 (9.2%). The prevalence of HPV in Iran is comparable to those reported in other regions of the world. In a similar manner, it seems that HPV types 6, 16 and11 are the most common types in Kerman. Additional studies on larger group of patients, particularly in those with pre-invasive forms of disease, are needed to explain the roles of different HPV types in this location of Iran.
引用
收藏
页码:5287 / 5291
页数:5
相关论文
共 50 条
  • [1] Comparison of the AdvanSure HPV GenoBlot assay with the INNO-LiPA HPV Genotyping assay for human papillomavirus genotyping
    Chung, Hae-Sun
    Lee, Miae
    JOURNAL OF CLINICAL VIROLOGY, 2014, 60 (01) : 34 - 38
  • [2] Comparison of AdvanSure HPV GenoBlot Assay with INNO-LiPA HPV Genotyping for Human Papillomavirus Genotyping
    Chung, H.
    Lee, M.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2013, 15 (06): : 884 - 884
  • [3] Performance of the New INNO-LiPA HPV Extra to Genotype Human Papillomavirus in Cervical Cell Specimens
    Galan-Sanchez, Fatima
    Hernandez-Menendez, Maite
    De los Rios Hernandez, Maria Angeles
    Rodriguez-Iglesias, Manuel
    ACTA CYTOLOGICA, 2011, 55 (04) : 341 - 343
  • [4] Comparison of Real-Time Multiplex Human Papillomavirus (HPV) PCR Assays with INNO-LiPA HPV Genotyping Extra Assay
    Else, Elizabeth A.
    Swoyer, Ryan
    Zhang, Yuhua
    Taddeo, Frank J.
    Bryan, Janine T.
    Lawson, John
    Van Hyfte, Inez
    Roberts, Christine C.
    JOURNAL OF CLINICAL MICROBIOLOGY, 2011, 49 (05) : 1907 - 1912
  • [5] Rapid identification of Mycobacteria to the species level using INNO-LiPA Mycobacteria, a reverse hybridization assay
    Suffys, PN
    Rocha, AD
    de Oliveira, M
    Campos, CED
    Barreto, AMW
    Portaels, F
    Rigouts, L
    Wouters, G
    Jannes, G
    Van Reybroeck, G
    Mijs, W
    Vanderborght, B
    JOURNAL OF CLINICAL MICROBIOLOGY, 2001, 39 (12) : 4477 - 4482
  • [6] Clinical Evaluation of INNO-LiPA HPV Genotyping EXTRA II Assay Using the VALGENT Framework
    Xu, Lan
    Padalko, Elizaveta
    Ostrbenk, Anja
    Poljak, Mario
    Arbyn, Marc
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2018, 19 (09)
  • [7] Comparison of INNO-LiPA Genotyping Extra and Hybrid Capture 2 assays for detection of carcinogenic human papillomavirus genotypes
    Barzon, Luisa
    Militello, Valentina
    Pagni, Silvana
    Palu, Giorgio
    JOURNAL OF CLINICAL VIROLOGY, 2012, 55 (03) : 256 - 261
  • [8] Human Papillomavirus Genotyping Using Archival Vulval Dysplastic or Neoplastic Biopsy Tissues: Comparison between the INNO-LiPA and Linear Array Assays
    Tan, Sarah E.
    Garland, Suzanne M.
    Rumbold, Alice R.
    Tabrizi, Sepehr N.
    JOURNAL OF CLINICAL MICROBIOLOGY, 2010, 48 (04) : 1458 - 1460
  • [9] Comparison of the INNO-LiPA and PapType Assays for Detection of Human Papillomavirus in Archival Vulva Dysplasia and/or Neoplasia Tissue Biopsy Specimens
    Tan, Sarah E.
    Garland, Suzanne M.
    Rumbold, Alice R.
    Tabrizi, Sepehr N.
    JOURNAL OF CLINICAL MICROBIOLOGY, 2011, 49 (11) : 3980 - 3982
  • [10] Subtyping analysis of hepatitis C virus using the Inno-LiPA assay and NS5B sequencing
    Gontcharova, V.
    Hebner, C.
    Martin, R.
    Ku, K. S.
    Miller, M. D.
    Mo, H.
    Svarovskaia, E. S.
    ANTIVIRAL THERAPY, 2013, 18 : A136 - A136